Pharmaguy interviews Brain Fox, Senior Partner at McKinsey, about the new e-book entitled "Pharma 3D: Rewriting the script for marketing in the digital age."

Topics for Discussion/Questions: 
Give us an short introduction to the e-book Pharma 3D. Why was this written now? Who collaborated in writing the book? What are the major takeaways for pharma?Explain why you think pharma is not doing enough in digital marketing Is it fair to compare pharma to other, more lightly regulated in terms of marketing, industries?The How-to section is extensive. What are the 3 Ds that pharma markets must know?What are your future plans for the book? Are you hoping to include more pharma-specific case studies?

Cindie Dilley, Head of New Patient Value Focus at UCB, talks about UCB's State ScoreCards program, which won the 2016 eyeforpharma #efpphilly award for Most Valuable Patient Initiative. 

What are ‘The Report Cards’ (aka ScoreCards)?

It is an interesting initiative to lobby decision makers for better access to innovative treatments for Epilepsy. The Record Cards ups the pressure on under-performing state health networks, by increasing transparency on state performance.

Why did they win? 

eyeforpharma judges were impressed by the way UCB managed to execute on a strategy to empower others to advocate for better care. It is a well-known truth that pharma is often perceived unwelcome in negotiations for access to innovative medicines. It is a reality of the industry business model that pharma has to battle to overcome access decision makers distrust of increased expenditure on new products.

UCB opened up the data on specialty care and newer anti-epileptic therapies and collaborated to issue independently peer-reviewed literature documenting the health benefits of a comprehensive up-to-date approach to manage this condition.

They then worked with local advocacy groups to share this knowledge along with transparent evaluations tracking the individual state performance on health outcomes. Armed with this information, patients were given the tools to challenge under-performing institutions and demand patient-centric change.

Pharmaguy interviews Wendy Blackburn, Executive Vice President at In Touch Solutions. Wendy talks about her company's #ALLin campaign to document patient stories, how she became a digitally-savvy woman pharma 'pioneer,' and her views on how digital devices such as wearables will transform the pharmaceutical and healthcare industries.

Pharmaguy interviews Lisa Valtierra, former Associate Director of Cross Cultural Marketing at Boehringer Ingelheim. We discuss how Boehringer Ingelheim engaged U.S. hispanics about diabetes in a culturally-relevant manner via TV, mobile, and the Web.
Telemundo was the media partner and produced "Bajo El Mismo Cielo"First-ever collaboration on a telenovela between pharma and Spanish media360 campaign that included a strong web-presence on Telemundo.com The character in the telenovela discussed type 2 diabetes in on-line vignettesEverything directed back to the campaign websiteCampaign also had a CRM componentCampaign won 7 awards ta DTC Multicultural Health Oct. 2015

Pharmaguy interviews Richard Meyer, Chief Digital Strategy Officer, Online Strategic Solutions, about a phone survey he conducted recently for a pharmaceutical client. We discuss the main findings of the survey.

Pharmaguy interviews Arsalan Arif, Publisher of Endpoints, about the benefits versus the drawbacks of content curation versus content marketing for pharmaceutical marketers in a social media world. We discuss the value of curated pharma/health content. Specifically:

Can pharma marketers do content curation? Or are they too focused on “content marketing?”

Pharmaguy interviews R.J. Lewis, President and CEO of eHealthcare Solutions, about his new book "RESULTS: The Future of Pharmaceutical and Healthcare Marketing," which he co-authored with Scott Weintraub, Brad Sitler, Joanne McHugh, Roger Zan, and Stephen Morales. 

The book covers 5 key themes:

Regional MarketingDigital MarketingBig DataEvolving Systems of Care & the ACAA view from the manufacturers perspective

RJ will focus on the chapter about digital marketing. Questions and topics we will touch on include:

What are some of the biggest trends you are seeing in digital marketing today?There is a shift from targeting contextually to targeting based on an audience, how is this playing out in digital marketing and where is it heading?What are some examples of “data driven” targeting in online advertising?What does the future hold for the newer media and platforms such as mobile and video?How big of a role does societies concerns over privacy play in how the future unfolds?For the chapter on a view from the manufacturer, I understand you interviewed over two dozen pharmaceutical executives. What are the main themes you heard from them?

Web Sites, Mobile Apps, Wearables Can Be Hacked!

Pharmaguy interviews Jeff Greene, digital strategy lead at New Solutions Factory. Jeff discusses the the impact on pharma marketing to physicians and consumers of the recent Ashley Madison hack and gives some advice on how to mitigate the risks.

Pharmaguy interviews digital consultant Len Starnes about the use of medical conference hashtags by the pharmaceutical industry.

The conversation covers these issues and questions:

What sparked this discussion about pharma's use of medical society conference hashtags?The authors of the analysis describe Twitter conference reporting as a 'backchannel', implying that it is somehow covert. Is it?Do you agree with the analysis that pharma disproportionately influences HCPs on conference hashtags?Do you support the authors of the analysis that all pharma tweets on conference hashtags constitute ‘detailing’?Should medical societies try to control conference hashtag use - is it possible or desirable?What exactly are the authors of the analysis proposing?Is self-regulation a better option for the pharma industry?

Activist Survey is a "Wake Up Call"

Pharmaguy interviews Jack Barrette, CEO of WEGO Health, who summarizes the result of the Pharma Edition of the 2015 WEGO Health Patient Engagement Survey.